Skip to main content

Mérieux Développement works alongside entrepreneurs whose products and services can bring genuine advances to the health of patients and consumers worldwide. Mérieux Développement is the financial arm of Institut Mérieux, which employs 16,500 persons globally and realized a turnover in excess of USD 3 billion in 2015.

Sienna Capital & Mérieux Développement

In 2014, Sienna Capital committed an amount of EUR 75 million dedicated to both funds managed by Mérieux Développement: Mérieux Participations I and Mérieux Participations II. Sienna Capital benefits from certain favourable financial terms for its support of Mérieux Participations II.

Financial year 2016

In 2016, Mérieux Participations II has invested in three new companies: Keranova, NovaCap and Le Noble Age for a total amount of EUR 40 million.